Apparent biliary pseudolithiasis during ceftriaxone therapy.
Biliary pseudolithiasis has been reported in patients who received ceftriaxone therapy. To examine this phenomenon further, serial gallbladder sonograms were evaluated in 44 adult patients who received intravenous ceftriaxone at 2 g or a placebo daily for 14 days in a double-blind controlled study....
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1990
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171774/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2203305/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.6.1146 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
